Back | Next |
home / stock / jspr / jspr message board
Subject | By | Source | When |
---|---|---|---|
Going up to test HOD so prob another | Welsh_Dragon | investorshub | 01/03/2023 7:33:20 PM |
Halt Insiders hilding the majority | IOUBLOKE1 | investorshub | 01/03/2023 7:24:44 PM |
Shaddy how they keeping holding it up I am | ZipCash | investorshub | 01/03/2023 7:00:03 PM |
Wow halt 9 | IOUBLOKE1 | investorshub | 01/03/2023 6:55:40 PM |
#$ABVC next to run big just like $JSPR | ZipCash | investorshub | 01/03/2023 6:29:55 PM |
37 million OS 6.36 FLOAT 91% INSIDERS AND institutiins 212000 short | IOUBLOKE1 | investorshub | 01/03/2023 6:15:20 PM |
Shorts might be coming in to short it | hondaboost | investorshub | 01/03/2023 5:35:59 PM |
$JSPR: FANTASTICCCCCCCCcccccccccccc runner | makinezmoney | investorshub | 01/03/2023 5:30:18 PM |
May be flying to $10. | hondaboost | investorshub | 01/03/2023 5:15:40 PM |
Because the buying are crazy and its rock | hondaboost | investorshub | 01/03/2023 5:14:34 PM |
Digital trading, the MM? Price action gyess cant ajust | IOUBLOKE1 | investorshub | 01/03/2023 3:53:02 PM |
why do they keep halting it? | madras50 | investorshub | 01/03/2023 3:42:12 PM |
Halted again $1.97. 3rd halt already. | Welsh_Dragon | investorshub | 01/03/2023 3:22:16 PM |
Good job I got .99 | Welsh_Dragon | investorshub | 01/03/2023 3:21:48 PM |
i got pre-market $1 on the dot | madras50 | investorshub | 01/03/2023 3:18:14 PM |
Who got pre market under $1 | Welsh_Dragon | investorshub | 01/03/2023 2:31:51 PM |
Turn back the clock | IOUBLOKE1 | investorshub | 01/03/2023 1:09:07 PM |
Wow | Docstemcell2020 | investorshub | 05/17/2022 4:54:47 PM |
znewcar1: JSPR 23% v326K c3.77 f37,8M H4.25 | znewcar1 | investorshangout | 05/03/2022 1:35:06 AM |
Does not look good | Docstemcell2020 | investorshub | 01/14/2022 7:26:36 PM |
News, Short Squeeze, Breakout and More Instantly...
Jasper Therapeutics Inc. Company Name:
JSPR Stock Symbol:
NASDAQ Market:
Jasper Therapeutics Inc. Website:
REDWOOD CITY, Calif., June 19, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel antibody therapy targeting c-Kit (CD117) to address mast cell driven diseases such as chronic spontaneou...
REDWOOD CITY, Calif., June 17, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a biotechnology company focused on development of briquilimab, a novel antibody therapy targeting c-Kit (CD117) to address mast cell driven diseases such as chronic spontaneous urticaria (CS...
2024-06-16 16:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...